Flavonoids Targeting the mTOR Signaling Cascades in Cancer: A Potential Crosstalk in Anti-Breast Cancer Therapy

Yaseen Hussain, Haroon Khan, Waqas Alam, Michael Aschner, Abdullah, Khalaf F. Alsharif, Luciano Saso

Research output: Contribution to journalReview articlepeer-review

Abstract

Cancer is one of the leading causes of death worldwide. Breast cancer is the second leading cause of death in women, with triple-negative breast cancer being the most lethal and aggressive form. Conventional therapies, such as radiation, surgery, hormonal, immune, gene, and chemotherapy, are widely used, but their therapeutic efficacy is limited due to adverse side effects, toxicities, resistance, recurrence, and therapeutic failure. Many molecules have been identified and investigated as potential therapeutic agents for breast cancer, with a focus on various signaling pathways. Flavonoids are a versatile class of phytochemicals that have been used in cancer treatment to overcome issues with traditional therapies. Cell proliferation, growth, apoptosis, autophagy, and survival are all controlled by mammalian target of rapamycin (mTOR) signaling. Flavonoids target mTOR signaling in breast cancer, and when this signaling pathway is regulated or deregulated, various signaling pathways provide potential therapeutic means. The role of various flavonoids as phytochemicals in targeting mTOR signaling pathways in breast cancer is highlighted in this review.

Original languageEnglish (US)
Article number4831833
JournalOxidative Medicine and Cellular Longevity
Volume2022
DOIs
StatePublished - 2022

ASJC Scopus subject areas

  • Biochemistry
  • Aging
  • Cell Biology

Fingerprint

Dive into the research topics of 'Flavonoids Targeting the mTOR Signaling Cascades in Cancer: A Potential Crosstalk in Anti-Breast Cancer Therapy'. Together they form a unique fingerprint.

Cite this